The CEO of the pharmaceutical company Moderna said that the production of Covid-19 vaccines will exceed demand next year and while this is a “good problem” for the world, it is not ideal for companies that make and sell the vaccines. strokes.
Speaking on Friday, Moderna CEO Stephane Bancel told attendees at a virtual event that his company was on track to produce one billion doses of their Covid-19 vaccine this year – enough for 500 million people.
Bancel predicted that there would actually be too much supply globally in 2022, with Moderna itself boosting production to 1.4 billion rounds. “Well, if anything this is a good problem in terms of managing the pandemic, but not a big problem if you make the vaccine, I guess” He said.
Also on rt.com
China supplies over 210 million Covid-19 vaccines, despite supply difficulties
Moderna’s boss said his company is working hard to roll out a booster vaccine for late summer or fall as the need shifts to protection against new variants of the virus. China says it will have the capacity to produce 5 billion shots by the end of the year, while India said it will produce 100 million shots of its indigenous vaccine, Covaxin, alone by September.
Britain, a relatively small country by population, will produce at least three vaccines, AstraZeneca, Novavax and Valneva, by the end of the year.
If you like this story, share it with a friend!